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Summary
Bacteria use several different secretion systems to 
deliver toxic EndoU ribonucleases into neighboring 
cells. Here, we present the first structure of a prokar-
yotic EndoU toxin in complex with its cognate immu-
nity protein. The contact-dependent growth 
inhibition toxin CdiA-CTSTECO31 from Escherichia coli 
STEC_O31 adopts the eukaryotic EndoU fold and 
shares greatest structural homology with the nucle-
ase domain of coronavirus Nsp15. The toxin contains 
a canonical His-His-Lys catalytic triad in the same 
arrangement as eukaryotic EndoU domains, but 
lacks the uridylate-specific ribonuclease activity 
that characterizes the superfamily. Comparative 
sequence analysis indicates that bacterial EndoU 
domains segregate into at least three major clades 
based on structural variations in the N-terminal sub-
domain. Representative EndoU nucleases from 
clades I and II degrade tRNA molecules with little 
specificity. In contrast, CdiA-CTSTECO31 and other 
clade III toxins are specific anticodon nucleases that 
cleave tRNAGlu between nucleotides C37 and m2A38. 
These findings suggest that the EndoU fold is a ver-
satile scaffold for the evolution of novel substrate 
specificities. Such functional plasticity may account 
for the widespread use of EndoU effectors by diverse 
inter-bacterial toxin delivery systems.
Introduction
Bacteria are social organisms that engage in coopera-
tive and antagonistic relationships with their neighbors. 
Many of these interactions are mediated by small signal-
ing molecules, such as quorum sensing auto-inducers, 
which coordinate group activities like biofilm formation 
and virulence gene expression (Lopez et al., 2010; Ng 
and Bassler, 2009). Diffusible inhibitory factors, such 
as antibiotics and bacteriocins, are exploited as weap-
ons to eliminate rivals (Cascales et al., 2007, Ghequire 
and De Mot, 2014). Research over the past decade has 
revealed that bacteria also antagonize their neighbors 
through direct delivery of protein toxins (Willett et al., 
2015; Souza et al., 2015; Whitney et al., 2017; Vassallo 
et al., 2017). This phenomenon was first discovered as 
“contact-dependent growth inhibition” (CDI) between 
different strains of Escherichia coli (Aoki et al., 2005). 
CDI is mediated by a subfamily of type V secretion sys-
tems (T5SS) that are widely distributed throughout pro-
teobacteria, fusobacteria and negativicutes (Aoki et al., 
2010; Zhang et al., 2012; Willett et al., 2015; Jones et 
al., 2017). T5SS/CDI+ bacteria use CdiB transporters 
to export and present filamentous CdiA proteins on the 
cell surface. CdiA proteins carry a variety of polymorphic 
C-terminal effector domains (CdiA-CT), which are trans-
ferred directly into neighboring bacteria upon binding 
specific receptors (Aoki et al., 2008; Beck et al., 2016; 
Ruhe et al., 2017). T5SS/CDI loci also encode immunity 
proteins that neutralize CdiA-CT toxin activity and protect 
the cell against self-inhibition. After the discovery of CDI, 
type VI secretion systems (T6SS) were also found to 
mediate proximity-dependent inter-bacterial competition 
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(Hood et al., 2010; MacIntyre et al., 2010). The T6SS is a 
bacteriophage-like contractile apparatus that injects pro-
tein effectors directly into nearby target bacteria (Basler 
et al., 2012). In contrast to CdiA effectors, which carry a 
single toxin domain, the T6SS apparatus supports simul-
taneous delivery of multiple toxins with distinct activities 
(Russell et al., 2014). Other secretion systems were first 
predicted to mediate inter-bacterial competition based on 
genetic linkage to toxin/immunity gene pairs. Zhang et 
al. predicted that Neisseria species export MafB toxins 
through type II secretion systems (T2SS), and that Gram-
positive bacteria use type VII secretion systems (T7SS) 
to deploy LXG/WXG100/ESAT-6 effectors (Zhang et al., 
2012). Those predictions were subsequently supported 
by experimental work showing that both systems produce 
toxins and mediate inter-cellular competition (Holberger 
et al., 2012; Jamet et al., 2015; Cao et al., 2016; Ohr 
et al., 2017; Whitney et al., 2017). Further experimental 
studies uncovered additional polymorphic toxin delivery 
systems. Bacillus and Listeria use large cell-wall associ-
ated YD-repeat proteins to exchange polymorphic toxin 
domains (Koskiniemi et al., 2013). Xanthomonas species 
deliver toxins though a specialized type IV secretion sys-
tem (Souza et al., 2015), and a type I secretion system 
mediates contact-dependent competition in Caulobacter 
crescentus (Garcia-Bayona et al., 2017). Most recently, 
polymorphic lipoprotein toxins were shown to inhibit cell 
growth when transferred between strains of Myxococcus 
xanthus through outer membrane exchange (Dey et al., 
2016; Vassallo et al., 2017). Collectively, these observa-
tions indicate that inter-cellular toxin exchange is a fun-
damental and ubiquitous facet of prokaryotic biology.
Toxin delivery mechanisms are manifold because the 
architecture of the bacterial cell envelope varies consider-
ably between phyla. Thus, systems capable of breaching 
the Gram-negative envelope are ineffective against Gram-
positive bacteria and vice versa. Nonetheless, divergent 
secretion systems from unrelated species often deploy 
closely related toxins. For example, uropathogenic E. coli 
isolates use T5SS/CdiA to deliver Ntox28 RNase domains 
into target bacteria (Beck et al., 2016). Ntox28 toxins also 
form the C-terminal domains of YD-peptide repeat pro-
teins and T7SS effectors from Gram-positive bacteria 
(Zhang et al., 2012; Diner et al., 2012). The Ntox28 tox-
ins of Gram-negative and Gram-positive bacteria share 
similar tRNA anticodon nuclease activities, and their cog-
nate immunity proteins are clearly homologous (Johnson 
et al., 2016). This sporadic distribution across unrelated 
species strongly suggests that toxin-immunity gene pairs 
are spread through horizontal gene transfer (Zhang et al., 
2012; Poole et al., 2011; Ruhe et al., 2016). In this model, 
newly acquired toxin-immunity sequences are integrated 
into resident secretion system loci through genetic recom-
bination (Aoki et al., 2010; Poole et al., 2011; Zhang et al., 
2012; Arenas et al., 2013; Unterweger et al., 2014). The 
modular organization of antibacterial effectors facilitates 
this process. Effector proteins are typically composites in 
which variable C-terminal toxins are fused to conserved 
N-terminal elements that guide export through a specific 
secretion system (Zhang et al., 2012; Koskiniemi et al., 
2013). Thus, polymorphic toxins are versatile payloads 
that can be delivered through several different secretion 
pathways.
EndoU (Endoribonuclease specific for uridylate) 
RNase domains are among the most commonly 
deployed toxins in bacterial competition (Zhang et al., 
2012). Aravind and colleagues first predicted that these 
toxins are related in structure and activity to eukaryotic 
and viral RNA processing enzymes (Zhang et al., 2012; 
Zhang et al., 2011). XendoU is the founding member of 
the EndoU superfamily and was isolated from Xenopus 
laevis as a uridylate specific endonuclease that releases 
small nucleolar RNAs from introns (Caffarelli et al., 1994; 
Caffarelli et al., 1997; Gioia et al., 2005; Laneve et al., 
2003). RNA viruses of the order Nidovirales also encode 
EndoU nucleases. Nidoviral EndoU (NendoU) domains 
form the C-termini of nonstructural proteins (Nsp) Nsp15 
in coronaviruses and Nsp11 in arteriviruses (Snijder et 
al., 2003; Nedialkova et al., 2009). These endonucle-
ases are essential for viral replication and have recently 
been shown to interfere with innate immune responses 
(Bhardwaj et al., 2004; Ivanov et al., 2004; Kindler et al., 
2017; Deng et al., 2017). XendoU and NendoU nucle-
ases have the same core built from two α/β subdomains 
and share a common catalytic triad that emanates from 
the N-terminal subdomain (Joseph et al., 2007; Renzi et 
al., 2006; Ricagno et al., 2006; Xu et al., 2006; Shi et al., 
2016; Zhang et al., 2017). Though unrelated in sequence 
and fold, EndoU and eukaryotic RNase A nucleases have 
remarkably similar active sites and use the same cata-
lytic mechanism to produce cyclic 2′-3′-phosphodiester 
and 5′-hydroxyl termini (Laneve et al., 2003; Ivanov et al., 
2004; Renzi et al., 2006; Ricagno et al., 2006; Nedialkova 
et al., 2009). Two bacterial EndoU toxins have been shown 
to have RNase activity (Holberger et al., 2012; Jamet et 
al., 2015), but there is currently no high-resolution struc-
tural information for the prokaryotic enzymes. Here, we 
present the first structure of a bacterial EndoU toxin-im-
munity protein complex from the T5SS/CDI system of E. 
coli STEC_O31. The CdiA-CTSTECO31
 nuclease domain 
adopts the EndoU fold and contains a canonical catalytic 
triad, but unexpectedly it lacks the characteristic uridylate 
specificity of the superfamily. Instead, CdiA-CTSTECO31 is 
an anticodon loop nuclease that preferentially cleaves 
after a cytidylate residue in tRNAUUC
Glu
. This unique 
specificity is correlated with a distinct architecture that 
differs from previously characterized prokaryotic EndoU 
toxins.
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Results
Structure of the CdiA-CT/CdiISTECO31 complex
We co-expressed the CdiA-CTSTECO31 toxin together with 
His6-tagged CdiI
STECO31
 immunity protein and purified the 
complex by Ni2+-affinity chromatography. Limited prote-
olysis with subtilisin was used to generate a complex 
that is suitable for crystallization (Fig. S1). This treatment 
removed the N-terminal “translocation” domain of CdiA-
CTSTECO31. This domain does not affect toxin activity, but 
is required to transfer the CdiA-CT into the cytoplasm 
of target bacteria (Willett et al., 2015). The truncated 
CdiA-CTSTECO31 and full-length CdiISTECO31 crystallized 
in space group P65 with one complex in the asymmetric 
unit. The structure was determined at 2.0 Å by the single 
wavelength anomalous dispersion approach using sele-
nomethionine (SeMet)-labeled proteins (Table 1). The 
final model contains residues Lys181 – Lys323 of CdiA-
CTSTECO31 and CdiISTECO31 residues Met1 – Pro120. The 
C-terminal domain of CdiA-CTSTECO31 adopts a V-shaped 
structure comprised of two α/β subdomains (Fig. 1A). The 
N-terminal subdomain consists of a β-hairpin (β1 and 
β2) followed by helix α1 and an antiparallel β-sheet. The 
sheet is composed of three major strands (β3, β4 and 
β6) and a shorter β5 strand that together with β6 flanks 
β4. The C-terminal subdomain begins at helix α2 and 
continues as an antiparallel β-sheet (β7, β8 and β9). The 
N-terminal tail crosses over to the adjacent subdomain, 
bringing the N- and C-termini into close proximity. The 
CdiISTECO31 immunity protein is composed of a core anti-
parallel β-sheet (β1′, β2′, β3′ and β4′) surrounded by heli-
ces α1′, α2′, α3′ and α4′ (Fig. 1A). The β-sheet is located 
topologically between helices α2′ and α3′. The immunity 
protein also contains three short sections (G1′, G2′ and 
G3′) that adopt 310-helical geometry (Fig. 1A).
CdiISTECO31 binds between the two subdomains of the 
toxin domain, with its β-sheet inserting into the toxin cleft 
(Fig. 1A). The N-terminus and helix α1′ of CdiISTECO31 
interact with the C-terminal subdomain of the toxin, and 
the long G1′ loop contacts the N-terminal subdomain 
(Fig. 1A). The interface buries approximately 1,600 Å2, 
corresponding to ~20% of the total solvent-accessi-
ble surface area as determined by PISA (Krissinel and 
Henrick, 2007). The interaction network is elaborate and 
features numerous direct contacts and more than 20 
water-mediated hydrogen bonds (Fig. 1B, Tables 2 and 
S1). Moreover, the toxin cleft is strongly electroposi-
tive, and several anionic residues from CdiISTECO31 form 
salt-bridges (Fig. 1C). Asp48 and Asp78 of CdiISTECO31 
form salt-bridges with toxin residues Lys261 and Lys181 
respectively. Arg307 and Tyr309 from the toxin also con-
verge on the main-chain carbonyl of CdiISTECO31 Asp48. 
CdiISTEO31 Tyr75 makes direct H-bond contacts with 
His187, Gly202 and His204 (Fig. 1B and Table 2). The 
side-chains of Trp17, Thr18, Asn28 and Glu29 emanate 
from CdiISTECO31 helix α1′ to make contacts with toxin res-
idues Gly293, Gln295, Asp298 and Arg307 respectively 
(Figs. 1B and C). Additionally, CdiISTECO31 Trp17 makes 
van der Waals contacts in a pocket formed by toxin resi-
dues Gln295 and Gln312 (Fig. 1C). The N-terminal sub-
domain of the toxin interacts primarily with CdiISTECO31 
helix α2′ and the long G1′ loop that links β2′ to β3′. Toxin 
residue Lys257 is the focal point of interactions with side-
chains of Asp34, Glu37 and Asn38 from immunity helix 
α2′ (Fig. 1B and C). Residues Asp61 and Ser63 from the 
G1′ loop form direct H-bonds with toxin residue Lys197 
(Fig. 1B and Table 2), and CdiISTECO31 Tyr60 packs against 
residues Ala243, Ala244 and Gly245, which form the 
β-turn connecting toxin strands β4 and β5 (Fig. 1C).
CdiA-CTSTECO31 contains an EndoU ribonuclease 
domain
Consistent with its annotation as an EndoU toxin, the 
DALI server returned eukaryotic EndoU domains as 
the closest structural homologs of CdiA-CTSTECO31 
(Holm and Rosenstrom, 2010). Coronaviral NendoU 
domains were the top hits in the search: coronavirus 
Table 1. Data processing and refinement statistics.
Processing
Wavelength (Å) 0.9793
Resolution range (Å)a 30.0 – 2.00 (2.03 – 2.00)
Space group P65
Unit cell parameters (Å) a = 89.43 b = 89.43 c = 76.15
Unique reflections 23,397 (1,192)
Multiplicity 6.3 (5.7)
Completeness (%) 99.2 (99.8)
<I >/< σI> 17.03 (2.21)
Wilson B factor (Å2) 21.0
Rmerge
b 0.117 (0.839)
CC1/2 0.689
CC* 0.903
Refinement
Resolution (Å) 30.00 - 2.00
Reflections work/test set 22,180/1,140
Rwork/Rfree 0.1674/0.2076
Average B factor (Å2) (No of 
atoms)
macromolecules 30.4 (2,125)
solvent 34.3 (194)
Rmsd bond lengths (Å) 0.014
Rmsd bond angles (°) 1.487
Ramachandran favoredd (%) 98.1
Ramachandran outliers (%) 0
Clashscored 0.72
aValues in parentheses correspond to the highest resolution shell.
bRmerge = ΣhΣj|Ihj–<Ih>|/ΣhΣjIhj, where Ihj is the intensity of obser-
vation j of reflection h.
cR = Σh|Fo|–|Fc|/Σh|Fo| for all reflections, where Fo and Fc are ob-
served and calculated structure factors respectively. Rfree is calcu-
lated analogously for the test reflections, randomly selected and 
excluded from the refinement.
dAs defined by Molprobity (Davis et al., 2004).
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229E Nsp15 (PDB:4S1T), Z = 6.1, rmsd 3.6 Å over 100 
Cα atoms; SARS Nsp15 (PDB:2RHB (Bhardwaj et al., 
2008)) Z = 6.0, rmsd 3.6 Å over 101 Cα atoms; SARS 
Nsp15 (PDB:2H85 (Ricagno et al., 2006)), Z = 6.0, rmsd 
3.5 Å over 100 Cα atoms, and murine hepatitis virus 
Nsp15 (PDB:2GTH (Xu et al., 2006)), Z = 5.5, rmsd 3.8 
Å for 101 Cα atoms. The NendoU domains and CdiA-
CTSTECO31 toxin have essentially identical topologies, 
though some secondary structure elements vary in 
length and relative position (Fig. 2A and B). Notably, 
NendoU domains harbor the two catalytic His residues 
within helix α8 and the adjacent loop, which corresponds 
to loop β2-α1 that follows the β1-β2 hairpin of the toxin 
domain (Figs. 2A and B). CdiA-CTSTECO31 also contains 
additional residues that form strand β5 and contribute 
to an elongated helix α2 (Fig. 2B). XendoU (PDB:2C1W 
(Renzi et al., 2006)) is more distantly related to the 
toxin at Z = 5.2, rmsd 3.1 Å over 108 Cα atoms. As with 
Nsp15, the XendoU active-site loop aligns poorly with 
the β1-β2 hairpin of the toxin (Fig. 2C and D). NendoU 
domains from arteriviral Nsp11 proteins show the low-
est structural similarity to the toxin. Nsp11 from porcine 
reproductive and respiratory virus (PDB:5DA1) was 
recovered at Z = 4.5 with rmsd 3.7 Å over 84 Cα atoms. 
Notably, sequence homology between CdiA-CTSTECO31 
and the eukaryotic EndoU domains is low, ranging 
from ~9% identity with XendoU up to about 15% for 
Fig. 1. Structure of the CdiA-CT/CdiISTECO31 complex. 
A. The CdiA-CT/CdiISTECO31 complex is depicted in cartoon with 
the toxin domain colored blue and the immunity protein colored 
green. Secondary structure elements are labeled with CdiISTECO31 
elements denoted by a prime (′) symbol. 
B. The toxin-immunity protein interface is depicted with selected 
side-chains forming direct hydrogen bonds (black dashed lines) 
shown in a stick representation. Water molecules that mediate 
interactions are shown as red spheres. 
C. Charge complementarity at the toxin-immunity protein interface. 
The electrostatic potential of the toxin surface was calculated 
using Coulomb’s law with Chimera (Pettersen et al., 2004). 
Potentials range from –10 kcal/mol*e (red) to +10 kcal/mol*e (blue). 
Water molecules that mediate interactions are shown as red 
spheres. [Colour figure can be viewed at wileyonlinelibrary.com]
Table 2. Direct H-bonds and salt-bridges at the CdiA-CT/
CdiISTECO31 interface.
CdiA-CT atom CdiI atom distance (Å)
Lys197 (NZ) Ser63 (O) 3.23
Lys257 (NZ) Glu37 (OE1) 2.81
Lys197 (NZ) Glu70 (OE2) 2.54
Lys257 (NZ) Asp34 (O) 3.16
Lys257 (NZ) Asp34 (OD1) 2.85
Lys261 (NZ) Asp48 (OD1) 3.30
Lys261 (NZ) Asp48 (OD2) 2.76
Lys197 (N) Asp61 (OD2) 3.26
Lys181 (NZ) Asp78 (OD2) 3.49
Lys257 (NZ) Asn38 (OD1) 2.77
His187 (NE2) Tyr75 (O) 2.84
His204 (NE2) Tyr75 (OH) 2.69
Gly202 (N) Tyr75 (OH) 2.70
Gln295 (NE2) Thr18 (OG1) 3.25
Asp298 (N) Asn2 (OD1) 2.80
Asn254 (ND2) Ile46 (O) 2.96
Asp298 (O) Asn2 (ND2) 3.11
Asp298 (OD2) Asn28 (ND2) 2.85
Asn254 (O) Asn38 (ND2) 3.01
Arg307 (NH1) Glu29 (OE1) 2.96
Arg307 (NE) Asp48 (O) 3.38
Arg307 (NH2) Asp48 (O) 2.74
Tyr309 (OH) Asp48 (O) 3.01
Asn292 (O) Tyr10 (N) 3.10
Gly293 (O) Trp17 (NE1) 2.92
Asn254 (OD1) Ile46 (N) 2.75
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the coronavirus NendoU domains (Fig. 2B and D). The 
structural homology search also recovered a handful of 
pseudopilin proteins from T2SSs. However, structural 
similarity with pseudopilins is limited to the C-terminal 
subdomain of the toxin.
Two prokaryotic EndoU toxins have been character-
ized to date. BC0920 from Bacillus cereus ATCC 14579 
is a putative T7SS effector that degrades rRNA and tRNA 
in vivo (Holberger et al., 2012). MafB1 from Neisseria 
meningitidis 8013 cleaves RNA after uridylate nucleo-
tides in vitro (Jamet et al., 2015). To determine whether 
CdiA-CTSTECO31 possesses similar activity, we expressed 
the toxin in E. coli and examined RNA for degradation. 
Although the toxin inhibited cell growth (Fig. S2A), there 
was no obvious RNase activity in the intoxicated cells 
(Fig. S2B). Because several CDI toxins cleave specific 
tRNAs (Nikolakakis et al., 2012; Willett et al., 2015; Jones 
et al., 2017; Michalska et al., 2017), we used Northern 
blot analysis to identify possible tRNA substrates. This 
screen revealed efficient cleavage of tRNAUUC
Glu
 in CdiA-
CTSTECO31 intoxicated cells, but not in cells expressing 
other toxins (Fig. 3). We also detected modest nuclease 
activity against tRNAGUC
Asp
, tRNAUUG
Gln
, tRNACCC
Gly
, 
tRNAUCC
Gly
, tRNAGCC
Gly
, tRNAUUU
Lys
, tRNAGGU
Thr
 and 
tRNACCA
Trp
 (Fig. 3). These results indicate that CdiA-
CTSTECO31 exhibits a tRNase activity that is novel for the 
EndoU superfamily.
CdiISTECO31 homologs and the specificity of immunity
A DALI server search for structural homologs of 
CdiISTECO31 returned NMB0503 from N. meningitidis 
MC58 (PDB ID:4Q7O, (Tan et al., 2015)) with Z = 13.4 
and rmsd 2.6 Å over 111 Cα atoms (Fig. 4A). Although 
it shares only ~16% sequence identity with CdiISTECO31 
(Fig. 4B), NMB0503 is probably an immunity protein 
Fig. 2. The CdiA-CTSTECO31 toxin is a prokaryotic EndoU domain. 
A. CdiA-CTSTECO31 (blue) and the C-terminal domain of SARS Nsp15 (PDB: 2H85, pink) were aligned using secondary structure matching 
(SSM) superposition calculated in Coot (Emsley and Cowtan, 2004). The β1-β2 hairpin of CdiA-CTSTECO31 and helix α8 in the NendoU active-
site loop are indicated. 
B. The sequences of the CdiA-CTSTECO31 and SARS Nsp15 C-terminal domains were aligned based on structure using DALI (Holm and 
Rosenstrom, 2010). The resulting sequence alignment was rendered using Espript (Robert and Gouet, 2014). Identical residues are 
highlighted in red, and similar residues are shown in red font. The predicted catalytic triad residues are marked with green stars. 
C. CdiA-CTSTECO31 (blue) and the C-terminal domain of XendoU (PDB: 2C1W, coral) were aligned by SSM superposition. The β1-β2 hairpin of 
CdiA-CTSTECO31 and helix α7 in the XendoU active-site loop are indicated. 
D. CdiA-CTSTECO31 and XendoU sequences were aligned as described in panel B. [Colour figure can be viewed at wileyonlinelibrary.com]
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Fig. 3. CdiA-CTSTECO31 is a specific tRNase. Northern blot analyses of RNA isolated from intoxicated E. coli cells. The C-terminal toxin 
domains of Rhs1 from E. cloacae ATCC 13047 (ECL Rhs1: YP_003612075.1), CdiA from K. pneumoniae 342 (Kpn 342: ACI08381.1), CdiA 
from E. coli STEC_O31 (STEC O31: EJK94116.1) and CdiA E. coli 3006 (EC3006: EKI34460.1) were expressed in E. coli, and total RNA was 
isolated for Northern blot hybridization using radiolabeled probes to the indicated tRNAs. Anticodon sequences are shown in parentheses 
for specific isoacceptors. Arrows to the left of the blot indicate cleavage products detected in CdiA-CTSTECO31 intoxicated cells. [Colour figure 
can be viewed at wileyonlinelibrary.com]
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because the upstream NMB0502 reading frame encodes 
a C-terminal EndoU domain that is 39% identical to CdiA-
CTSTECO31 (Fig. 4C). Moreover, NMB0502 has the same 
tRNase activity as CdiA-CTSTECO31 when expressed in 
E. coli (Fig. S3). The structures of the two immunity pro-
teins deviate in three regions: (i) NMB0503 contains an 
N-terminal helix (α0′) that is absent from CdiISTECO31; (ii) 
the loop connecting β2′ to β3′ is extended in NMB0503 
and contains an additional 310 helix and (iii) CdiISTECO31 
contains a 310 helix (G2′) in the loop connecting β3′ to β4′ 
(Fig. 4B). Given that these secondary structure elements 
interact with the toxin domain in the CdiA-CT/CdiISTECO31 
structure (Fig. 4A), the discrepancies may reflect the 
toxin-free state of NMB0503 (Tan et al., 2015). However, 
NMB0502 diverges from CdiA-CTSTECO31 in regions 
that interact directly with CdiISTECO31 (Fig. 4C), suggest-
ing that these differences are critical for specific bind-
ing interactions between toxins and cognate immunity 
proteins. This conclusion is supported by alignments 
of closely related EndoU toxins and immunity proteins, 
which show that each pair possesses a unique set of res-
idues contributing to the binding interface (Fig. S4).
To explore the specificity of immunity proteins, 
we tested whether EndoU toxins can be neutralized 
by near-cognate CdiI. We first fused the cdiA-CT/ 
cdiISTECO31 module to the cdiAEC93 gene of E. coli EC93, 
thereby generating a plasmid-borne CDI system capa-
ble of delivering CdiA-CTSTECO31 toxin into E. coli target 
cells. Inhibitor cells expressing the chimeric CDISTECO31 
system significantly outcompeted E. coli target bacte-
ria when seeded at a 1:1 ratio in co-culture (Fig. 5A). 
Northern blot analysis revealed cleaved tRNAUUC
Glu
 in 
the mixed culture (Fig. 5C). Because inhibitor cells are 
immune to the toxin, the latter result suggests that most 
of the tRNAUUC
Glu
 is degraded in target bacteria. Target 
cells expressing CdiISTECO31 were protected from both 
Fig. 4. Structure-based alignment of CdiISTECO31 and the NMB0503 immunity protein of N. meningitidis MC58. 
A. CdiISTECO31 (green) and NMB0503 (PDB: 4Q7O, magenta) were aligned by SSM superposition. The CdiA-CTSTECO31 toxin domain (blue) is 
included to illustrate the toxin-immunity protein binding interface. The bottom view is rotated 40° with respect to the top view. 
B. CdiISTECO31 and NMB0503 sequences were aligned based on structure using DALI. The CdiIYmo43969 immunity protein from Y. mollaretii 
ATCC 43968 was aligned using Clustal-Omega. The resulting alignment was rendered using Espript (Robert and Gouet, 2014) with identical 
residues highlighted in red, and similar residues shown in red font. Green circles below the alignment indicate CdiISTECO31 residues that form 
direct H-bonds with the EndoU domain of CdiA-CTSTECO31. 
C. EndoU toxins from E. coli STEC_O31, Y. mollaretii ATCC 43969 and N. meningitidis MC58 were aligned using Clustal-Omega. The 
resulting alignment was rendered using Espript (Robert and Gouet, 2014) with identical residues highlighted in red, and similar residues 
shown in red font. Blue circles below the alignment indicate CdiA-CTSTECO31 residues that form direct H-bonds with CdiISTECO31 immunity 
protein. [Colour figure can be viewed at wileyonlinelibrary.com]
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growth inhibition and tRNase activities (Fig. 5A and C). 
By contrast, targets expressing near-cognate NMB0503 
were inhibited to the same extent as cells with no immu-
nity gene (Fig. 5A), and Northern blot showed that 
NMB0503 failed to neutralize tRNase activity (Fig. 5C). 
We then tested whether a more closely related immunity 
protein blocks CdiA-CTSTECO31. The T5SS/CDI locus of 
Yersinia mollaretii ATCC 43969 encodes an EndoU toxin 
and immunity protein that are ~55% and ~58% identi-
cal to CdiA-CTSTECO31 and CdiISTECO31 respectively (Fig. 
4B and C). Despite this homology, cdiIYmo43969 expres-
sion did not protect target cells from CDISTECO31 medi-
ated growth inhibition (Fig. 5A and C). To confirm that 
the cdiIYmo43969 construct produces functional immunity 
protein, we tested it against inhibitor cells that express 
a CdiAEC93-CTYmo43969 fusion protein. The chimeric 
CDIYmo43969 system is less potent than CDISTECO31 (com-
pare Fig. 5B to A), but toxic nuclease activity was detected 
in co-cultures with non-immune target cells (Fig. 5D). As 
expected, target cells that express CdiIYmo43969 were 
immune to CDIYmo43969 mediated growth inhibition and 
nuclease activity, but near-cognate CdiISTECO31 failed to 
protect target bacteria (Figs. 5B and 5D). Surprisingly, 
we found that NMB0503-expressing target cells were 
not killed in co-culture with CDIYmo43969 inhibitors (Fig. 
5B). Nevertheless, cleaved tRNAUUCGlu accumulated 
in this latter co-culture (Fig. 5D), demonstrating that 
NMB0503 immunity protein does not completely block 
tRNase activity. Presumably, the NMB0503 expressing 
target cells retained enough full-length tRNA to support 
growth. Taken together, these results indicate that each 
EndoU toxin-immunity protein interaction is distinct.
Fig. 5. Specificity of CdiI immunity function. E. coli inhibitor strains that deploy CdiA-CTSTECO31 (panel A) or CdiA-CTYmo43969 (panel B) 
were cultured at a 1:1 ratio with E. coli target cells that express the indicated cdiI immunity genes. Viable inhibitor and target bacteria were 
enumerated as colony forming units (cfu) at t = 0 and after 1 h of co-culture CDISTECO31 competitions (panel A) and 3 h for CDIYmo43969 
competitions (panel B). The competitive index = (cfut = finaltargets/cfut = finalinhibitors)/(cfut = 0targets/cfut = 0inhibitors). Competitive indices for four 
independent experiments are reported together with mean ± standard error. Northern blot analysis of total RNA isolated from CDISTECO31 
(panel C) and CDIYmo43969 (panel D) competition co-cultures. One sample was collected immediately after mixing (t = 0 h) and all other 
samples were collected after 1 h of co-culture. Carets indicate cleavage products, and the asterisk indicates an incompletely processed 
tRNAGAU
Ile
 transcript that accumulates in CdiA-CTSTECO31 intoxicated cells. [Colour figure can be viewed at wileyonlinelibrary.com]
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The EndoU nuclease active site
Eukaryotic EndoU nucleases cleave phosphodiester 
bonds using a His-His-Lys catalytic triad (Ivanov et al., 
2004; Guarino et al., 2005; Shi et al., 2016; Kang et al., 
2007; Nedialkova et al., 2009). The EndoU catalytic 
mechanism is similar to that of RNase A, which uses two 
His residues to mediate proton transfers and Lys to stabi-
lize the pentavalent phosphoryl transition-state (Findlay 
et al., 1962; Deavin et al., 1966; Cuchillo et al., 2011). 
Structural superimposition suggests that toxin residues 
His187 and His204 are equivalent to the catalytic His 
residues in SARS Nsp15 (His234/His249) and XendoU 
(His162/His178) (Fig. 6A). Further, CdiA-CTSTECO31 
Lys261 is positioned near Lys289 of Nsp15 and Lys224 
of XendoU (Fig. 6A). The EndoU active site also contains 
conserved residues that contribute to uridylate specificity. 
Ser293 of SARS Nsp15 (Ser174 in EAV Nsp11, Ser228 in 
XendoU) is predicted to form a H-bond with O2 of uracil, 
and Tyr342 (Tyr216 in EAV Nsp11, Tyr280 in XendoU) is 
thought to stack onto the pyrimidine ring (Bhardwaj et 
al., 2008; Nedialkova et al., 2009). The structure over-
lay suggests that CdiA-CTSTECO31 residues Thr262 and 
His321 may also function in substrate discrimination 
(Fig. 6A). Finally, toxin residue Pro322 superimposes 
closely onto conserved Pro residues that are required for 
Nsp15 nuclease activity (Fig. 6A) (Ricagno et al., 2006; 
Bhardwaj et al., 2008).
We probed the CdiA-CTSTECO31 active site using site-di-
rected mutagenesis. We first introduced Ala substitutions 
into the CdiAEC93-CTSTECO31 chimera and tested inhibition 
activity in competition co-cultures. Mutation of His187, 
His204, Lys261, Thr262 and His321 abrogated growth 
inhibition (Fig. 6B). In contrast, substitution of Asn319 in 
Fig. 6. The CdiA-CTSTECO31 active site. 
A. Superimposition of XendoU and SARS Nsp15 active-site residues onto CdiA-CTSTECO31. Side-chains from SARS Nsp15 are shown in pink, 
and those from XendoU are in coral. CdiA-CTSTECO31 residues are rendered in blue and labeled with black font. 
B. E. coli inhibitors that deploy the indicated CdiA-CTSTECO31 variants were cultured at 1:1 ratio with E. coli target cells. Viable inhibitor and 
target bacteria were enumerated as colony forming units (cfu) at t = 0 and t = 1 h, and the competitive index calculated. Competitive indices 
for four independent experiments are reported together with mean ± standard error. 
C. Northern blot analysis of tRNAGlu isolated from the competition co-cultures in panel B.
D. In vitro activities of CdiA-CTSTECO31 variants. The indicated toxins were purified and incubated with E. coli total RNA for 30 min at 37 °C. 
Reactions were analyzed by Northern blot using a probe to tRNAUUC
Glu
. [Colour figure can be viewed at wileyonlinelibrary.com]
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the toxin active site had no discernable effect on inhibition 
activity (Fig. 6B). Immunoblot analysis confirmed that each 
CdiA variant was produced at the same level as the wild-
type effector (Fig. S5). Furthermore, the mutated effectors 
were susceptible to degradation with extracellular protein-
ase K (Fig. S5), indicating that each was exported to the 
cell surface properly. Although target bacteria were not 
inhibited by cells deploying the Lys261Ala and Thr262Ala 
toxin variants (Fig. 6B), we detected tRNase activity in 
these co-cultures (Fig. 6C). Presumably, these latter tox-
ins are attenuated enough to allow target cell growth. 
We then compared the activities of mutant toxins to wild-
type CdiA-CTSTECO31 using in vitro nuclease assays. 
Purified wild-type toxin cleaved tRNAUUC
Glu
 efficiently, 
but its activity was neutralized when purified CdiISTECO31 
immunity protein was included in the reaction (Fig. 6D). 
The His204Ala substitution appeared to ablate nuclease 
activity, and toxins carrying His187Ala and Lys261Ala 
substitutions exhibited little activity in vitro (Fig. 6D). The 
Thr262Ala and His321Ala substitutions also significantly 
reduced nuclease activity compared to wild-type (Fig. 6D). 
Purified Asn319Ala toxin retained nuclease activity (Fig. 
6D), consistent with its near wild-type function in the com-
petition co-culture experiments (Fig. 6C). These results 
suggest that CdiA-CTSTECO31 uses the same metal-inde-
pendent catalytic mechanism as RNase A and eukaryotic 
EndoU nucleases. Consistent with this model, we found 
that purified CdiA-CTSTECO31 retains robust tRNase activ-
ity in reactions supplemented with EDTA (Fig. S6). Thus, 
the CdiA-CTSTECO31 EndoU domain appears to function 
as a metal-independent phosphotransferase.
Prokaryotic EndoU toxins have evolved into three clades
The tRNase activity of CdiA-CTSTECO31 differs from 
previously characterized EndoU toxins, suggesting 
the superfamily may have evolved a broader spec-
trum of substrate specificities. Analysis of EndoU toxin 
sequences from predicted T5SS/CdiA effector proteins 
shows that the domains segregate into at least three 
major clades. Clade I domains are related to the pre-
viously characterized MafB1 toxin from N. meningitidis 
8013 (Jamet et al., 2015) (Fig. 7A). Clade I toxins are 
characterized by greatly abbreviated N-terminal subdo-
mains that lack the α1, β3, β4 and β5 elements of CdiA-
CTSTECO31 (Fig. S7). Clade I toxins contain additional 
residues between α2 and β7 in the C-terminal subdo-
main and sometimes carry extended C-terminal tails 
(Fig. S7). Clade II toxins are similar to BC0920 from B. 
cereus ATCC 14579 and are predicted to lack helix α1 
(Figs. 7A and S7). CdiA-CTSTECO31, CdiA-CTYmo43969 
and NMB0502 contain clade III nuclease domains (Fig. 
Fig. 7. Diversification of prokaryotic EndoU toxin domains. 
A. EndoU domains from predicted CdiA proteins were aligned using Clustal-Omega, and the associated unrooted tree rendered using the 
Tree of Life website. The source multiple sequence alignment is presented in Fig. S7, which also lists the NCBI Refseq accession numbers 
for each protein. EndoU domains from N. meningitidis MafB1 and B. cereus BC0920 are included for comparison. 
B. In vitro activities of EndoU toxins. The indicated toxins were purified and incubated with E. coli total RNA in the absence or presence of 
cognate immunity protein. Reactions were analyzed by Northern blot hybridization with probes to the indicated RNAs. [Colour figure can be 
viewed at wileyonlinelibrary.com]
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7A). All EndoU domains are predicted to carry the two 
catalytic His residues within a β-hairpin, though the 
spacing of these residues varies amongst toxins (Fig. 
S7). Clades I and III contain the catalytic Lys residue 
within a conserved K-(S/T) motif in strand β6 (Fig. S7). 
The equivalent Lys residues are not easily identified in 
clade II, though many of these toxins contain irregularly 
spaced K-(S/T) motifs within the β5 region (Fig. S7).
To directly compare nucleases from each EndoU clade, 
we purified representative toxins and examined their 
RNase activities in vitro. For clade I, we chose a predicted 
CdiA-CT from Klebsiella aerogenes GN05224, reasoning 
that it should be functional when fused to CdiAEC93 to gen-
erate a chimeric effector. Additionally, the CdiA-CTGN05224 
EndoU domain shares 61% sequence identity with the 
previously characterized N. meningitidis MafB1 toxin 
(Jamet et al., 2015). Purified CdiA-CTGN05224 degrades 5S 
rRNA and several tRNA species in vitro (Fig. 7B). Similar 
RNase activity was detected in competition co-cultures 
with inhibitor cells that deploy CdiA-CTGN05224, though 
5S rRNA degradation was not observed in vivo (Fig. S8), 
presumably because it is protected by ribosomal proteins. 
We also found that CdiA-CTGN05224 RNase activity is 
effectively neutralized by CdiIGN05224 immunity protein in 
vitro (Fig. 7B) and in vivo (Fig. S8). We chose B. cereus 
BC0920 as a representative clade II toxin and found that 
its RNase activity is similar to that of CdiA-CTGN05224 
(Fig. 7B). Like the other nucleases, BC0920 activity was 
suppressed when the reaction was supplemented with 
purified BC0921 immunity protein (Fig. 7B). Finally, we 
confirmed the substrate specificity of CdiA-CTSTECO31 
toxin in vitro. Purified CdiA-CTSTECO31 cleaves tRNAUUC
Glu
 
efficiently and shows partial activity on tRNAGCC
Gly
, but 
has no discernable activity on tRNAGAU
Ile
, tRNAGUA
Tyr
 or 
5S rRNA (Fig. 7B). Moreover, CdiA-CTSTECO31 is most 
likely a specific endonuclease, because it produces stable 
5′ and 3′ fragments of tRNAUUC
Glu
 (Fig. 7B).
Finally, we mapped the CdiA-CTSTECO31 cleavage site 
within tRNAUUC
Glu
. The comparable sizes of the 5′ and 
3′ fragments suggest that the toxin cleaves tRNAUUC
Glu
 
in the anticodon loop. Therefore, we designed an oligo-
nucleotide that anneals downstream of the anticodon for 
primer extension analysis (Fig. 8A). Analysis of 3′-frag-
ments generated from in vivo toxin expression revealed 
cleavage at the 5′-side of m2A38 (Fig. 8B and C). This 
same site was observed in tRNAUUC
Glu
 isolated from com-
petition co-cultures. As expected, these cleavages were 
not detected in cells that express cdiISTECO31 (Fig. 8B). We 
also determined the same cleavage site in tRNAUUC
Glu
 
digested with purified CdiA-CTSTECO31 in vitro (Fig. 8B). 
This latter result confirms that CdiA-CTSTECO31 is directly 
responsible for producing the 3′-fragment, and strongly 
suggests that the toxin cleaves the phosphodiester linking 
nucleotides C37 and m2A38 (Fig. 8C, red arrow).
Discussion
Aravind and colleagues first identified the link between 
eukaryotic EndoU RNases and a broadly distributed fam-
ily of antibacterial toxins (Zhang et al., 2012; Zhang et al., 
2011). The structure of CdiA-CTSTECO31 confirms those 
predictions, and mutational analysis suggests that this 
toxin uses the same catalytic mechanism as eukaryotic 
EndoU nucleases. However, there are also significant dif-
ferences between the prokaryotic and eukaryotic nucle-
ases. Purified XendoU and Nsp15 are only active in the 
presence of millimolar Mn2+ or Ca2+ (Laneve et al., 2003; 
Schwarz and Blower, 2014; Ivanov et al., 2004; Bhardwaj 
et al., 2004), whereas the bacterial toxins examined 
here have no metal requirement. There is no direct role 
for divalent metal in the EndoU catalytic mechanism 
(Ricagno et al., 2006; Renzi et al., 2006), and like the 
bacterial toxins, arteriviral Nsp11 is active in the absence 
of metal (Nedialkova et al., 2009). These observations 
suggest that metals may promote XendoU and Nsp15 
nuclease activity through allostery. This model is consis-
tent with data showing that SARS Nsp15 undergoes con-
formational changes upon titration with Mn2+ (Bhardwaj 
et al., 2004). Allosteric regulation could be mediated by 
the additional structural elements found in eukaryotic 
EndoU enzymes. Bacterial EndoU domains are about 
half the size of XendoU, which contains ~150 additional 
N-terminal residues that form an extensive α-helical cra-
dle that surrounds and supports the nuclease core (Renzi 
et al., 2006). In this model, conformational changes in 
the supporting cradle would reshape the active-site cleft 
and/or alter the configuration of the catalytic triad. The 
supporting structures in NendoU domains are abbrevi-
ated, but Nsp11 and Nsp15 contain additional N-terminal 
domains that mediate oligomerization (Bhardwaj et al., 
2008; Ricagno et al., 2006). Oligomerization is critical for 
Nsp15 activity because the active-site loop is stabilized 
by the β10-β11 “supporting loop”, which is in turn con-
formationally constrained by the neighboring protomer 
(Joseph et al., 2007; Guarino et al., 2005). In monomeric 
Nsp15, the active-site loop is untethered and migrates 
into the substrate-binding groove, where it presumably 
blocks the interaction with substrate RNA. Similarly, one 
of the active-site loops is disordered in crystal structures 
of homodimeric Nsp11, again raising the possibility that 
RNase activity is regulated through multimerization (Shi 
et al., 2016; Zhang et al., 2017; Joseph et al., 2007). These 
findings suggest that eukaryotic EndoU proteins must be 
carefully controlled because unrestrained RNase activity 
is lethal. Such allosteric control should not be required of 
prokaryotic EndoU nucleases, because these enzymes 
are used to inhibit bacterial cell growth. Nevertheless, 
the potent toxic effects of EndoU nucleases must be sup-
pressed in the producing cell, thus providing the selective 
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pressure to evolve immunity proteins that protect against 
self-intoxication.
The narrow substrate specificity of CdiA-CTSTECO31 is 
surprising given that all previously characterized EndoU 
enzymes cleave RNAs after uridylate. The determinants 
governing EndoU nuclease specificity have been exam-
ined most extensively for viral NendoU proteins. Ser293 
in Nsp15 (Ser228 in XendoU) is predicted to form specific 
H-bond contacts with uracil, and Ala substitutions at this 
position relax specificity and increase the rate of cleavage 
at cytidylate nucleotides (Ricagno et al., 2006; Bhardwaj 
et al., 2008; Nedialkova et al., 2009). The corresponding 
residue in CdiA-CTSTECO31 is Thr262, which is able to form 
the same H-bond contacts with uracil as Ser. Moreover, 
Thr residues at this position have been shown to pro-
mote uridylate specificity in other NendoU-containing 
proteins (Bhardwaj et al., 2008; Nedialkova et al., 2009). 
Nevertheless, CdiA-CTSTECO31 does not recognize 
uridylate and instead cleaves tRNAUUC
Glu
 between nucle-
otides C37 and m2A38. The in vivo toxin activity screen 
suggests that the C37-A38 motif is a positive recognition 
determinant, because tRNAGUC
Asp
 and tRNAGly isoaccep-
tors share this element and are subject to partial cleavage. 
However, the toxin probably monitors the overall structure 
of the anticodon loop, because it discriminates against 
the tRNAGUC
Asp
 anticodon, which differs from tRNAUUC
Glu
 
only at nucleotide 35. All of the clade III toxins examined 
here have anticodon nuclease activity, suggesting that 
their shared architecture determines substrate specificity. 
Clade III domains are characterized by helix α1, which is 
apparently absent from the other clades. Helix α1 sup-
ports the β1-β2-hairpin in the CdiA-CTSTECO31 structure, 
Fig. 8. CdiA-CTSTECO31 is an anticodon nuclease. 
A. tRNAUUC
Glu
 sequence showing the hybridized reverse transcriptase (RT) primer and oligonucleotide standards used to map the CdiA-
CTSTECO31 cleavage site. 
B. Primer extension analysis. RNA was isolated competition co-cultures and cells intoxicated by intracellular CdiA-CTSTECO31 expression. 
Samples from in vitro nuclease assays were also analyzed. The neutralizing effect of CdiISTECO31 was tested where indicated. The reverse 
transcriptase (RT) primer was radiolabeled, hybridized to tRNAUUCGlu, and extended with reverse transcriptase. Reactions and radiolabeled 
marker oligonucleotides were run on a 50% urea, 15% polyacrylamide gel and visualized by phosphorimaging. 
C. Position of CdiA-CTSTECO31 cleavage within the tRNAUUC
Glu
 anticodon loop. Modified nucleotides are highlighted in red. [Colour figure can 
be viewed at wileyonlinelibrary.com]
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and therefore it is conceivable that this structural element 
shapes the active-site cleft. We note that clade III also 
contains toxins from Pseudomonas and Acinetobacter 
species that appear to lack strand β5 in the N-terminal 
subdomain (see Fig. S7). It will be of interest to deter-
mine whether these enzymes share anticodon nuclease 
activity with CdiA-CTSTECO31 or perhaps exhibit distinct 
substrate specificities.
The EndoU superfamily is one of the most widely used 
toxins in inter-bacterial competition. Aravind and col-
leagues initially identified EndoU effectors associated with 
T2SS/MafB, T5SS, T6SS and T7SS delivery platforms 
Table 3. Plasmids.
Plasmid Descriptiona Reference
pTrc99a IPTG-inducible expression plasmid, AmpR GE Healthcare
pTrc99KX Derivative of pTrc99a with additional 5′ KpnI, and 3′ SpeI and XhoI restriction sites, AmpR Koskiniemi et al. (2014)
pMCSG58 LIC overexpression vector containing argU and ileX tRNA genes, AmpR Eschenfeldt et al. (2013)
pMCSG76 Over-expression vector with Clo DF13 origin of replication, SpcR StrR Eschenfeldt et al. (2013)
pMCSG88 LIC overexpression vector containing argU and ileX tRNA genes and Clo DF13 origin of 
replication, SpcR StrR
This study
pDAL8914 Constitutive expression of chimeric cdiAEC93-CTGN05224 and cdiIGN05224 genes, CmR This study
pDAL8924 pTrc99KX::cdiIGN05224, AmpR This study
pDAL8956 pET28A(+)::cdiA-CT//cdiIGN05224, KanR This study
pMCSG58-
APC200204
pMCSG58::cdiA-CT/cdiISTECO31, AmpR This study
pMCSG88-
APC111471
pMCSG88::cdiISTECO31, SpcR StrR This study
pCH450 pACYC184 derivative with E. coli araBAD promoter for arabinose-inducible expression, 
TetR
Hayes and Sauer (2003)
pCH2408 Constitutive expression of chimeric cdiAEC93-CTSTECO31 and cdiISTECO31 genes, CmR This study
pCH4066 pTrc99KX::cdiIYmo43969, AmpR This study
pCH4496 pTrc99KX::cdiISTECO31, AmpR This study
pCH6278 pUC57::cdiA-CT/cdiISTECO31, AmpR Genscript
pCH6290 pUC57::cdiA-CT/cdiIYmo43969, AmpR Genscript
pCH6505 pET21S::cdiA-CT/cdiIDd3937, AmpR Aoki et al. (2010)
pCH8102 pET21::BC0921, AmpR This study
pCH9273 pET21::BC0920-CT/BC0921, AmpR Holberger et al. (2012)
pCH10163 Cosmid pCdiA-CT/pheS* that carries a kan-pheS* cassette in place of the E. coli EC93 
cdiA-CT/cdiI coding sequence. Used for allelic exchange and counter-selection. CmR 
KanR
Morse et al. (2012)
pCH11140 pCH450::rhsA-CT/rhsIECL-DAS, TetR This study
pCH11884 pET21::cdiA-CT/cdiISTECO31, AmpR This study
pCH12158 pCH450::cdiA-CT/cdiIKpn342-DAS, TetR This study
pCH12599 pCH450::cdiA-CT/cdiIEC3006-DAS, TetR Willett et al. (2015)
pCH12847 Constitutive expression of chimeric cdiAEC93-CTYmo43969 and cdiIYmo43969 genes, CmR This study
pCH12964 pET21::cdiA-CT(N319A)/cdiISTECO31, AmpR This study
pCH12966 pET21::cdiA-CT(H321A)/cdiISTECO31, AmpR This study
pCH13215 Constitutive expression of chimeric cdiAEC93-CT(H321A)STECO31 and cdiISTECO31 genes, 
CmR
This study
pCH13306 Constitutive expression of chimeric cdiAEC93-CT(H204A)STECO31 and cdiISTECO31 genes, 
CmR
This study
pCH13307 Constitutive expression of chimeric cdiAEC93-CT(N319A)STECO31 and cdiISTECO31 genes, 
CmR
This study
pCH13308 pCH450::cdiA-CT/cdiISTECO31-DAS, TetR This study
pCH13309 Constitutive expression of chimeric cdiAEC93-CT(T262A)STECO31 and cdiISTECO31 genes, 
CmR
This study
pCH13527 pCH450::NMB0502/NMB0503-DAS, TetR This study
pCH13629 pET21::cdiA-CT(H204A)/cdiISTECO31, AmpR This study
pCH13638 pTrc99KX::NMB0503, AmpR This study
pCH13639 pET21::cdiISTECO31, AmpR This study
pCH13703 pET21::cdiA-CT(T262A)/cdiISTECO31, AmpR This study
pCH13871 Constitutive expression of chimeric cdiAEC93-CT(H187A)STECO31 and cdiISTECO31 genes, 
CmR
This study
pCH13881 Constitutive expression of chimeric cdiAEC93-CT(K261A)STECO31 and cdiISTECO31 genes, 
CmR
This study
pCH14224 pET21::cdiA-CT(H187A)/cdiISTECO31, AmpR This study
pCH14226 pET21::cdiA-CT(K261A)/cdiISTECO31, AmpR This study
pCH14368 pET21::cdiIGN05224, AmpR This study
aAbbreviations: AmpR, ampicillin-resistance; CmR, chloramphenicol-resistance; KanR, kanamycin-resistance; SpcR, spectinomycin-resist-
ance; StrR, streptomycin-resistance; and TetR, tetracycline-resistance.
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(Zhang et al., 2012; Holberger et al., 2012; Jamet et 
al., 2015). More recent database searches indicate that 
EndoU domains are deployed by several other systems 
– some of which have been previously described and oth-
ers that appear to be novel. We identified bacterial EndoU 
domains fused to the C-termini of PrsW, SpvB and MuF-
like phage-head morphogenesis proteins (Table S2), all of 
which have been proposed to deliver polymorphic toxins 
(Zhang et al., 2012). Intriguingly, EndoU nuclease are also 
fused to VgrG-like proteins in Gram-positive Paenibacillus 
species (Table S2). VgrG is a critical structural compo-
nent of T6SS and often carries C-terminal toxin domains 
(Russell et al., 2014; Ho et al., 2014). However, T6SSs 
have only been characterized in Gram-negative bacte-
ria, and Paenibacillus genomes contain no recognizable 
T6SS core genes. Nevertheless, these VgrG proteins are 
encoded together with DUF4280 (PAAR-like) and penta-
peptide repeat adaptor proteins that are similar to those 
found in T6SS effector operons from Gram-negative bac-
teria. We also found a PAAR-like protein with a C-terminal 
EndoU domain in Clostridium sp. ASBs410 (Table S2). 
Together, these observations strongly suggest that Gram-
positive bacteria possess phage-like secretion systems 
that are functionally analogous to T6SS. In addition to 
these recognizable toxin delivery systems, we identi-
fied EndoU-containing proteins with unusual N-terminal 
domains and several others that contain no other con-
served domains whatsoever (Table S2). Some of these 
proteins carry N-terminal secretion signal sequences, and 
nearly all are encoded together with probable immunity 
proteins. We speculate that these latter uncharacterized 
proteins are also used for inter-bacterial toxin delivery. 
Finally, we identified a handful of extraordinarily large (1.5 
to 2.9 MDa) proteins from Actinobacteria that carry internal 
EndoU domains. These proteins typically contain one or 
more APH aminoglycoside phosphotransferase domains 
together with a variety of RNA/DNA-binding modules 
(Table S3). The function of these proteins is not known, but 
they appear unlikely to mediate inter-cellular competition 
given the central location of the EndoU domain and the 
absence of linked immunity genes. The unusual domain 
assemblage suggests that these enormous proteins could 
process nucleic acids, or perhaps synthesize secondary 
metabolites or antibiotics in a manner similar to polyketide 
synthases. Regardless of their precise activities, these lat-
ter proteins suggest that EndoU domains have also been 
coopted to perform non-inhibitory functions in bacteria.
Experimental Procedures
Plasmid constructions
Plasmid constructs and oligonucleotides used in this 
study are listed in Tables 3 and S4 respectively. DNA 
fragments encoding CdiA-CT/CdiI proteins from E. coli 
STEC_O31 and Y. mollaretii ATCC 43969 were syn-
thesized by Genscript (Piscataway, NJ) and supplied in 
plasmid pUC57. The fragment from E. coli STEC_O31 
(Genbank: AFEX01000038) encodes residues Val2931 – 
Lys3253 of CdiASTECO31 (locus tag: ECSTECO31_4009) 
and CdiISTECO31 (ECSTECO31_4008). The initiation 
codon for ECSTECO31_4008 is not annotated cor-
rectly, and CdiISTECO31 contains 121 residues. The frag-
ment from Y. mollaretii ATCC 43969 (NCBI reference: 
NZ_AALD02000043.1) encodes residues Val2694 – 
Asn2963 of CdiAYmo43969 (YMOLL0001_RS03095) and 
its putative CdiIYmo43969 immunity protein (YMOLL0001_
RS0219640). A fragment encoding Val1 – Lys360 of 
CdiA-CTGN05224 (YA39_RS24095) and CdiIGN05224 
(YA39_RS16570) from K. aerogenes GN05224 (NCBI 
reference: NZ_LDBZ01000036.1) was synthesized by 
GenArt Gene Synthesis (ThermoFisher) and provided 
in plasmid pMA-T. The cdiA-CT/cdiISTECO31 module was 
amplified with primers 204F40 and 204R49 and intro-
duced into plasmid pMCSG58 using ligation-indepen-
dent cloning (LIC) (Eschenfeldt et al., 2013; Eschenfeldt 
et al., 2010; Eschenfeldt et al., 2009). All of the resulting 
clones contained frame-shift mutations in the toxin coding 
region, suggesting that the toxin was not completely neu-
tralized by CdiISTECO31. Therefore, cdiISTECO31 was ampli-
fied with primer pair 204CdiIF/04R49 and introduced 
into plasmid pMCSG88 as described above. Vector 
pMCSG88 was generated by digesting pMCSG58 with 
HindIII/NcoI, followed by ligation to plasmid pMCSG76 
(Eschenfeldt et al., 2013). The resulting pMCSG88 con-
struct contains the LIC site with the Clo DF13 origin of 
replication and a spectinomycin-resistance marker. 
The pMCSG58-CdiA-CT/CdiISTECO31 and pMCSG88- 
CdiISTECO31 expression vectors were then introduced into 
E. coli BL21(DE3) to generate an over-expression strain 
for large-scale protein purification and crystallography.
The cdiA-CT/cdiISTECO31 (CH3538/CH3539) and 
NMB0502/NMB0503 (CH2839/CH2785) modules were 
amplified and ligated to NcoI/SpeI-digested plasmid 
pCH12599 to tag the immunity proteins with C-terminal 
ssrA(DAS) degrons. The cdiA-CT/cdiISTECO31 product was 
also ligated to pCH6505 to generate plasmid pCH11884 
for the purification of CdiA-CT/CdiISTECO31 complex for 
biochemical analyses. This latter plasmid was also used 
as a template for PCR-based site-directed mutagene-
sis using primers CH4016, CH4017, CH4018, CH4019, 
CH4269 and CH4270. The cdiA-CT/cdiIGN05224 module 
was amplified with primers SK724/DL3986 and ligated 
to pET28a via NcoI/XhoI restrictions sites to generate 
plasmid pDAL8956. The cdiISTECO31 (CH3854/CH3539), 
cdiIGN05224 (SK733/DL3986) and BC0921 (CH4398/
CH1706) immunity genes were also cloned into pET21S 
for the purification of His6-tagged immunity proteins under 
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non-denaturing conditions. The cdiISTECO31 (CH3854/
CH3624), cdiIGN05224 (SK733/SK734), NMB0503 
(CH2784/CH2785) and cdiIYmol43969 (CH3976/CH3977) 
genes were also cloned into pTrc99a derivatives to test 
for immunity function in competition co-cultures.
Plasmid-borne chimeric CDI systems were con-
structed by allelic exchange of the counter-select-
able pheS* marker from plasmid pCH10163 (Morse et 
al., 2012). Wild-type and mutant cdiA-CT/cdiISTECO31 
sequences were amplified with primers CH3172/CH3569 
and fused to fragments amplified from regions upstream 
and downstream of the cdiAEC93 gene. The upstream 
homology fragment was amplified using primer pair 
CH4100/CH4101 and the downstream fragment with 
primers CH4102/CH4103. The three products were then 
fused to each other using overlap-extension PCR with 
primers CH4100/CH4103. The final DNA product (100 
ng) was electroporated together with plasmid pCH10163 
(300 ng) into E. coli DY378 cells (Thomason et al., 2007). 
Recombinant plasmid clones were selected on yeast 
extract glucose-agar supplemented with 33 µg/mL chlor-
amphenicol and 10 mM D/L-p-chlorophenylalanine. The 
same procedure was used to fuse the cdiA-CT/cdiIYmol43969 
and cdiA-CT/cdiIGN05224 modules (amplified primers 
CH3747/CH3748 and SK693/SK694 respectively) to the 
E. coli EC93 CDI system.
Protein expression and purification for crystallization
E. coli BL21(DE3) cells carrying pMCSG58-CdiA-CT/
CdiISTECO31 and pMCSG88-CdiISTECO31 were grown at 
37 °C for 6 - 8 h in LB medium supplemented with 
ampicillin (100 μg/mL) and spectinomycin (50 μg/mL). 
A portion of the culture (0.5 mL) was diluted into 50 
mL of M9 minimal medium supplemented with 0.5% 
glycerol, 100 μg/mL of ampicillin, 50 μg/mL of spec-
tinomycin, trace minerals and vitamins for overnight 
culture at 37 °C. Large-scale cultures were grown to 
an optical density at 600 nm (OD600) of 0.8 then cooled 
to 18 °C. SeMet was added to a final concentration 
of 60 μg/mL together with L-isoleucine, L-leucine, 
L-lysine, L-phenylalanine L-threonine and L-valine to a 
final concentration of 100 μg/mL and incubated for 20 
min. Protein expression was induced with 0.5 mM iso-
propyl-D-thiogalactopyranoside (IPTG) for overnight 
culture. Cells were harvested by centrifugation the 
next day, and the pellets washed and resuspended 
in 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 10 mM 
2-mercaptoethanol (2-ME), 10% glycerol. Cells were 
broken with Fast Break reagent (Promega) supple-
mented with 10 μg/mL lysozyme, 500 U Benzonase 
Nuclease HC (Novagen) and Complete Protease 
Inhibitor Cocktail (Roche, Mannheim, Germany). The 
lysate was clarified by centrifugation at 10,000 × g for 
1 h, followed by passage through a 0.22 μm filter prior 
to loading onto a 5 mL Nickel (II) Sepharose HisTrap 
column (GE Healthcare Biosciences). The column 
was washed with 5 volumes of 50 mM Tris-HCl (pH 
8.0), 500 mM NaCl, 20 mM imidazole, 10% glycerol, 
followed by elution with 250 mM imidazole in the 
same buffer. Fractions were pooled and loaded onto 
a Hiload 26/60 Superdex 200 size-exclusion column 
equilibrated with 20 mM Tris-HCl (pH 7.5), 150 mM 
NaCl and 2 mM dithiothreitol (DTT). Fractions con-
taining two proteins were pooled and concentrated to 
14 mg/mL using an Amicon Ultracel 20K concentrator 
(Millipore).
Crystallization, data collection, structure solution and 
refinement
The protein sample was treated with subtilisin (20 
ng/μL) on ice overnight prior to crystallization trials. 
Crystallization conditions were screened using the 
Pi-PEG Screen HTS (Jena Biosciences GmBh). The 
complex was crystallized in 10.7% PEG 4000, 50 mM 
Tris-HCl (pH 8.0), 8.6% PEG 3000 at 4 °C by sitting-drop 
vapor diffusion in 96-well Crystal Quick plates (Greiner 
Bio-one). Prior to flash cooling in liquid nitrogen, the 
crystals were cryo-protected in mother liquor supple-
mented with 17% glycerol. The single-wavelength anom-
alous diffraction (SAD) dataset was collected at 100 K 
near the selenium K-absorption edge on beamline 19-ID 
at the Advanced Photon Source, Argonne National 
Laboratory. Diffraction images were processed with 
the HKL3000 suite (Minor et al., 2006). Intensities were 
converted to structure factor amplitudes in Ctruncate 
(French and Wilson, 1978; Padilla and Yeates, 2003) 
from the CCP4 package (Winn et al., 2011). Data collec-
tion and processing statistics are presented in Table 1. 
The structure was solved using the HKL3000 software 
pipeline (Minor et al., 2006) by the SAD method with Se 
peak data. The pipeline applied SHELXD for the search 
of heavy atom sites and SHELXE for initial phases cal-
culations (Sheldrick, 2008). The phases were improved 
through iterations of MLPHARE (Otwinowski, 1991) and 
DM (Cowtan, 1994). The initial protein model was built 
in HKL-Builder utilizing Buccaneer (Cowtan, 2006). The 
final model was obtained through alternating manual 
rebuilding in COOT (Emsley and Cowtan, 2004) and 
crystallographic refinement in Refmac (Murshudov et 
al., 1997; Winn et al., 2011). The protocol refinement 
included optimization of TLS parameters with 5 and 
2 groups defined for chains A (CdiA-CTSTECO31) and I 
(CdiISTECO31) respectively. The refinement statistics are 
presented in Table 1. The atomic coordinates and struc-
ture factors have been deposited in the Protein Data 
Bank under accession code 5HKQ.
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Protein purification and in vitro nuclease assays
Cultures of E. coli CH2016 harboring expression plas-
mids were grown to OD600 ~ 0.7, and expression was 
induced with 1.5 mM IPTG. After incubation for 2 h, cells 
were harvested and frozen at –80 °C. Cell pellets were 
re-suspended in lysis buffer [20 mM sodium phosphate 
(pH 7.0), 150 mM NaCl, 10 mM 2-ME, 0.05% Triton X-100] 
and broken by two French press passages at 20,000 psi. 
Cell debris was removed by centrifugation at 16,000 × g 
at 4 °C. His6-tagged immunity proteins were purified by 
Ni2+-affinity chromatography in lysis buffer and eluted 
with 250 mM imidazole as described (Nikolakakis et al., 
2012). EndoU toxins were first purified in complex with 
His6-tagged immunity proteins, then eluted from the 
column by denaturation in 6 M guanidine-HCl, 20 mM 
sodium phosphate (pH 7.0). Purified proteins were dia-
lyzed against 20 mM sodium phosphate (pH 7.0), 150 mM 
NaCl, 10 mM 2-ME. Proteins were quantified by absor-
bance at 280 nm using the following extinction coeffi-
cients: CdiA-CTSTECO31, 25,330 cm–1 M–1; CdiISTECO31, 
20,400 cm–1 M–1; CdiA-CTGN05224, 47,330 cm–1 M–1; 
CdiIGN05224, 7,450 cm–1 M–1; BC0920, 22,920 cm–1 M–1 
and BC0921, 15,470 cm–1 M–1.
In vitro nuclease assays were performed in 20 mM Tris-
HCl (pH 7.5), 150 mM NaCl using E. coli total RNA (0.5 mg 
mL–1) as a substrate. Reactions were initiated by addition 
of 2 µM purified toxins, followed by incubation for 30 min 
at 37 °C. Where indicated, reactions were supplemented 
with 2 to 6 µM purified immunity protein. Reactions were 
quenched with denaturing gel-loading buffer and run on 
50% urea-10% polyacrylamide gels buffered with 1 × Tris-
borate EDTA. Gels were stained with ethidium bromide or 
electroblotted to positively charged nylon membranes for 
subsequent Northern blot analyses.
In vivo toxin activity and competition co-cultures
Nuclease activity screens were performed by activating 
toxins from Enterobacter cloacae ATCC 13047 (Whitney 
et al., 2014) and E. coli isolates STEC_O31, 3006 and 
96.154 inside E. coli X90 cells. Each cognate immunity 
protein was tagged with a C-terminal ssrA(DAS) degron 
as described (McGinness et al., 2006; Poole et al., 2011). 
E. coli X90 cells carrying these expression constructs 
were seeded at OD600 ~ 0.05 in LB media supplemented 
with 25 µg/mL tetracycline and incubated with shaking 
at 37 °C. After 2 h, the cultures were adjusted to 0.2% 
L-arabinose and cultured for an additional 4 h. Cell 
growth was monitored by measuring the OD600 every 30 
min. Culture samples were harvested into an equal vol-
ume of ice-cold methanol after 2 h of induction, and the 
cells frozen at –80 °C for subsequent RNA extraction and 
analysis.
Bacterial competitions were conducted in shaking LB 
broth at 37 °C. Media were seeded with inhibitor and target 
strains at a 1:1 ratio, and the co-culture incubated for 1 to 3 
h. E. coli EPI100 cells that express chimeric CDI systems 
were used as inhibitors. Inhibitor strains carried plasmids 
pCH2408 (wild-type CDISTECO31), pCH13871 (His187Ala), 
pCH13306 (His204Ala), pCH13881 (Lys261Ala), 
pCH13309 (Thr262Ala), pCH13307 (Asn319Ala), 
pCH13215 (His321Ala), pDAL8914 (CDIGN05224) or 
pCH12847 (CDIYmo43969). E. coli MC4100 target strains 
carried plasmids pTrc99A (cdiI–), pCH4496 (cdiISTECO31), 
pCH4066 (cdiIYmo43969), pDAL8924 (cdiIGN05224) 
or pCH13638 (cdiIMC58). Viable inhibitor and target cells 
were enumerated as colony forming units per mL (CFU 
mL–1) on selective media at the beginning and end of 
co-culture. Competitive indices were calculated as the 
ratio of target cells to inhibitor cells at the end of co-cul-
ture divided by the initial target to inhibitor cell ratio. 
Competitive indices are reported for each independent 
experiment together with the average ± standard error of 
the mean. Co-culture samples were also harvested into 
equal volumes of ice-cold methanol for RNA extraction.
RNA isolation and analyses
Frozen cell pellets were resuspended in guanidinium 
isothiocyanate (GITC)-phenol and total RNA extracted 
as described (Garza-Sánchez et al., 2006). RNAs (5 µg) 
were run on 50% urea-10% polyacrylamide gels buffered 
with 1 × Tris-borate EDTA and electroblotted to positively 
charged nylon membranes for Northern blot analysis. 
Blots were hybridized with [32P]-labeled oligonucleotide 
probes that are specific for individual E. coli tRNAs 
(see Table S4) (Garza-Sánchez et al., 2006; Hayes and 
Sauer, 2003). Blots were visualized by phosphorimaging 
using Bio-Rad Quantity One software. Primer extension 
analysis was performed as described (Beck et al., 2014) 
using oligonucleotide CH4275 to map the cleavage site 
in tRNAUUC
Glu
. The primer and marker oligonucleotides 
were 5′-radiolabeled with [32P] using T4 polynucleotide 
kinase. The radiolabeled primer was hybridized with 
RNA samples for 5 min at 50 °C, then extended with 
Superscript reverse transcriptase at 37 °C for 30 min. 
Reactions were quenched with denaturing gel-loading 
buffer and heated to 95 °C. Primer extension reactions 
were run on a 50% urea, 15% polyacrylamide gel buff-
ered with 1 × Tris-borate-EDTA and visualized on a Bio-
Rad phosphorimager using Quantity One software.
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